\BOOKMARK [1][]{section.12}{0 Project Setup}{}% 1
\BOOKMARK [1][]{section.13}{1 Introduction}{}% 2
\BOOKMARK [1][]{section.15}{2 Fundamentals and Related Work}{}% 3
\BOOKMARK [2][]{subsection.16}{2.1 From Probabilistic Language Models to modeling Evolution Theory}{section.15}% 4
\BOOKMARK [2][]{subsection.26}{2.2 GISAID EpiFlu Data Platform}{section.15}% 5
\BOOKMARK [2][]{subsection.28}{2.3 Domain-Specific Methodologies to create Evolutionary Datasets for Mutation Prediction}{section.15}% 6
\BOOKMARK [2][]{subsection.29}{2.4 Previous Work on Mutation Prediction}{section.15}% 7
\BOOKMARK [2][]{subsection.30}{2.5 Sequence-to-Sequence Models based on Long Short-Term Memory}{section.15}% 8
\BOOKMARK [2][]{subsection.36}{2.6 Applying Generative Adversarial Networks}{section.15}% 9
\BOOKMARK [2][]{subsection.38}{2.7 Transformer and Attention Mechanism}{section.15}% 10
\BOOKMARK [1][]{section.44}{3 Approach}{}% 11
\BOOKMARK [2][]{subsection.46}{3.1 Dataset Creation}{section.44}% 12
\BOOKMARK [3][]{subsubsection.47}{3.1.1 Raw Data Selection from GISAID}{subsection.46}% 13
\BOOKMARK [3][]{subsubsection.50}{3.1.2 Generation of a Phylogenetic Tree}{subsection.46}% 14
\BOOKMARK [3][]{subsubsection.52}{3.1.3 Phylogenetic Tree to Dataset}{subsection.46}% 15
\BOOKMARK [2][]{subsection.53}{3.2 Data Preprocessing}{section.44}% 16
\BOOKMARK [3][]{subsubsection.54}{3.2.1 Dimensionality Reduction by selecting Subpart of the Genome}{subsection.53}% 17
\BOOKMARK [3][]{subsubsection.55}{3.2.2 Transformation of Genome Sequence to Numeric Model Input}{subsection.53}% 18
\BOOKMARK [2][]{subsection.56}{3.3 Model Architecture}{section.44}% 19
\BOOKMARK [2][]{subsection.59}{3.4 Training Process}{section.44}% 20
\BOOKMARK [1][]{section.62}{4 Experimental Results}{}% 21
\BOOKMARK [2][]{subsection.63}{4.1 Dataset Insights}{section.62}% 22
\BOOKMARK [3][]{subsubsection.64}{4.1.1 Complete Dataset}{subsection.63}% 23
\BOOKMARK [3][]{subsubsection.67}{4.1.2 Preprocessed Dataset}{subsection.63}% 24
\BOOKMARK [2][]{subsection.70}{4.2 Evaluation}{section.62}% 25
\BOOKMARK [3][]{subsubsection.71}{4.2.1 Evaluation Criteria}{subsection.70}% 26
\BOOKMARK [3][]{subsubsection.73}{4.2.2 Training Phase and Evaluation}{subsection.70}% 27
\BOOKMARK [1][]{section.76}{5 Conclusion}{}% 28
\BOOKMARK [1][]{appendix.77}{A Appendix}{}% 29
\BOOKMARK [2][]{subsection.78}{A.1 Appendix A: Basics from Molecular Biology}{appendix.77}% 30
\BOOKMARK [3][]{subsubsection.79}{A.1.1 Genome Sequences}{subsection.78}% 31
\BOOKMARK [3][]{subsubsection.82}{A.1.2 Protein Biosynthesis}{subsection.78}% 32
\BOOKMARK [3][]{subsubsection.88}{A.1.3 Structure of SARS-CoV-2}{subsection.78}% 33
\BOOKMARK [3][]{subsubsection.93}{A.1.4 Relationships between Biological Objects}{subsection.78}% 34
